ArticleProceedings of the National Academy of Sciences of the United States of America2020

In situ genetic engineering of tumors for long-lasting and systemic immunotherapy.

Stephany Y Tzeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.